Alu profiling of primary and metastatic nonsmall cell lung cancer

被引:9
作者
Furmaga, WB
Ryan, JL
Coleman, WB
Cole, SR
Tsongalis, GJ
机构
[1] Hartford Hosp, Dept Pathol & Lab Med, Hartford, CT 06102 USA
[2] Univ N Carolina, Chapel Hill, NC USA
关键词
pulmonary metastatic carcinoma; microsatellite; alu; PCR; pulmonary nonsmall cell carcinoma;
D O I
10.1016/S0014-4800(03)00016-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The metastatic potential of nonsmall cell carcinoma of lung (NSCLC), is currently recognized post factum, when lymph nodes or distant organs are already involved. Our ability to determine which tumors have acquired metastatic potential could help direct therapy to be more aggressive or less aggressive based upon this information. Evaluation of microsatellite instability via detection of LOH at specific loci may be useful in identifying specific markers and/or genes associated with this process. We examined Alu insertional elements as a potential marker of genetic changes associated with the metastatic potential of NSCLC. We analyzed archived, paraffin embedded tissue from 20 proven cases of NSCLC. DNA was extracted from 10 micron paraffin sections and amplified using an Alu PCR protocol. This technique does not examine specific loci but rather results in a banding profile of cellular genomic DNA. Informative allelic banding patterns, noted as differences between primary and metastatic lesions from the same patient, were observed in five of six cases (83%) with intrapulmonary metastases and in only nine of 14 (64%) cases with extrapulmonary metastases. Multiple genomic changes were detected in metastatic tumor cells as compared to normal lung tissue or primary lung tumor tissue. It appears that Alu profiling may be useful in the detection of metastatic vs primary lesions, and this technique may offer a method for identifying novel genes responsible for tumor progression and metastases. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:224 / 229
页数:6
相关论文
共 53 条
[1]  
Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO
[2]  
2-J
[3]   Microsatellite instability [J].
Atkin, NB .
CYTOGENETICS AND CELL GENETICS, 2001, 92 (3-4) :177-181
[4]   Lung cancer staging [J].
Barker, JM ;
Silvestri, GA .
CURRENT OPINION IN PULMONARY MEDICINE, 2002, 8 (04) :287-293
[5]   Mitochondrial genome instability in human cancers [J].
Bianchi, NO ;
Bianchi, MS ;
Richard, SM .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2001, 488 (01) :9-23
[6]  
Burnett R J, 1999, Surg Oncol Clin N Am, V8, P231
[7]  
COLBY TV, 1995, TUMORS LOWER RESP TR
[8]   Molecular prognostic markers in breast cancer [J].
Dahiya, R ;
Deng, GR .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :185-200
[9]  
Diebold J, 1999, HISTOL HISTOPATHOL, V14, P269, DOI 10.14670/HH-14.269
[10]  
Duval A, 2002, CANCER RES, V62, P2447